Skip to content

Radioprotective Light-weight Caps in the Interventional Cardiology Setting

Radioprotective Light-weight Caps in the Interventional Cardiology Setting: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01620658
Acronym
PROTECT
Enrollment
197
Registered
2012-06-15
Start date
2012-08-31
Completion date
2014-04-30
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Occupational Exposure to Radiation

Keywords

Occupational Exposure to Radiation

Brief summary

The primary objective of the present trial is to compare the radiation attenuation provided by XPF caps (0.5mm lead-equivalent and 0.3mm lead-equivalent) to the standard protection (fabric cap, basically no protection) as measured in % radiation attenuation) during 150 days of fluoroscopy guided cardiology interventions. The second objective is to compare the operator comfort (rated on a visual analog scale) of wearing the XPF protection caps compared to the standard fabric caps.

Detailed description

The primary objective of the present trial is to compare the radiation attenuation provided by XPF caps (0.5mm lead-equivalent and 0.3mm lead-equivalent) to the standard protection (fabric cap, basically no protection) as measured in % radiation attenuation) during 150 days of fluoroscopy guided cardiology interventions. The second objective is to compare the operator comfort (rated on a visual analog scale) of wearing the XPF protection caps compared to the standard fabric caps. For more information please contact Dr. Raul Herrera, MD, Director Baptist Cardiac and Vascular Institute Baptist Hospital of Miami.

Interventions

DEVICE0.5mm XPF cap

Interventionalist wear a XPF 0.5mm lead equivalent cap during fluoroscopy guided interventions. XPF is a trademark of BloXR (Salt lake City, UT) for a new bi-layer (Barium/Bismuth) radiation attenuation material.

DEVICE0.3mm XPF cap

Interventionalist wear a XPF 0.3mm lead equivalent cap during fluoroscopy guided interventions. XPF is a trademark of BloXR (Salt lake City, UT) for a new bi-layer (Barium/Bismuth) radiation attenuation material.

DEVICEStandard cap

Interventionalist wear a standard fabric cap during fluoroscopy guided interventions.

Sponsors

Baptist Health South Florida
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Interventional Cardiologist practicing in Baptist Cardiac & Vascular Institute * cardiac procedure requiring C-arm fluoroscopy

Exclusion criteria

* Interventional Neuroradiologists and Interventional Radiologists will not be included in this study.

Design outcomes

Primary

MeasureTime frameDescription
Radiation Attenuation in Percentage (%)1 dayThe null hypothesis is that the XPF 0.5mm lead-equivalent caps attenuation is equal to the XPF 0.3mm lead-equivalent and standard cap attenuations. The alternative hypothesis is that the XPF 0.5mm lead-equivalent cap attenuation is superior or inferior to the XPF 0.3mm lead-equivalent and standard cap attenuations. The groups will be compared separately and a pooled analysis, comparing XPF 0.5mm and 0.3mm combined vs. standard is also planned.The radiation protection (radiation dose reduction) expressed as a percentage was calculated by subtracting radiation measured underneath the cap from radiation measured outside the cap and then dividing this difference by the product of radiation measured outside the cap multiplied by 100.
Absolute Radiation Exposure Outside of Cap1 dayThe cumulative radiation doses were defined as the summation of all correspondent equivalent doses measured.

Secondary

MeasureTime frameDescription
Operator Comfort Assessment1 day per participant, a total of 197 operator daysAfter completion of the last procedure on each day, the operators were asked to rate the comfort of wearing the cap on a scale from 0 (unbearably heavy, badly fitting) to 100 (very light, well fitting).
Operator Comfort Assessment Based on Weight1 day per participant, a total of 197 operator daysAfter completion of the last procedure on each day, the caps worn by the operators were weighed to assess comfort of wearing the standard cap, XPF 0.3mm and XPF 0.5mm caps. The operators were asked to rate the comfort of wearing the cap on a scale from 0 (unbearably heavy, badly fitting) to 100 (very light, well fitting).

Countries

United States

Participant flow

Recruitment details

Patients presenting to the Miami Cardiac and Vascular Institute for Imaging Study/Procedure.

Pre-assignment details

Voluntary patient participation. PI responsible for patient selection.

Participants by arm

ArmCount
Standard Cap
Interventionalist wear a standard fabric cap during fluoroscopy guided interventions. Standard cap: Interventionalist wear a standard fabric cap during fluoroscopy guided interventions.
59
0.3mm XPF Cap
Interventionalist wear a XPF 0.3mm lead equivalent cap during fluoroscopy guided interventions. 0.3mm XPF cap: Interventionalist wear a XPF 0.3mm lead equivalent cap during fluoroscopy guided interventions. XPF is a trademark of BloXR (Salt lake City, UT) for a new bi-layer (Barium/Bismuth) radiation attenuation material.
74
0.5mm XPF Cap
Interventionalist wear a XPF 0.5mm lead equivalent cap during fluoroscopy guided interventions. 0.5mm XPF cap: Interventionalist wear a XPF 0.5mm lead equivalent cap during fluoroscopy guided interventions. XPF is a trademark of BloXR (Salt lake City, UT) for a new bi-layer (Barium/Bismuth) radiation attenuation material.
64
Total197

Baseline characteristics

CharacteristicStandard Cap0.3mm XPF Cap0.5mm XPF CapTotal
Age, Continuous53 years53 years53 years53 years
Region of Enrollment
United States
59 participants74 participants64 participants197 participants
Sex: Female, Male
Female
29 Participants36 Participants30 Participants95 Participants
Sex: Female, Male
Male
30 Participants38 Participants34 Participants102 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 590 / 740 / 64
other
Total, other adverse events
0 / 590 / 740 / 64
serious
Total, serious adverse events
0 / 590 / 740 / 64

Outcome results

Primary

Absolute Radiation Exposure Outside of Cap

The cumulative radiation doses were defined as the summation of all correspondent equivalent doses measured.

Time frame: 1 day

Population: The primary objective of the trial is to show how much radiation attenuation is provided by XPF in absolute and relative terms.

ArmMeasureValue (MEAN)
Standard CapAbsolute Radiation Exposure Outside of Cap132 uSv
0.3mm XPF CapAbsolute Radiation Exposure Outside of Cap118 uSv
0.5mm XPF CapAbsolute Radiation Exposure Outside of Cap59 uSv
Primary

Radiation Attenuation in Percentage (%)

The null hypothesis is that the XPF 0.5mm lead-equivalent caps attenuation is equal to the XPF 0.3mm lead-equivalent and standard cap attenuations. The alternative hypothesis is that the XPF 0.5mm lead-equivalent cap attenuation is superior or inferior to the XPF 0.3mm lead-equivalent and standard cap attenuations. The groups will be compared separately and a pooled analysis, comparing XPF 0.5mm and 0.3mm combined vs. standard is also planned.The radiation protection (radiation dose reduction) expressed as a percentage was calculated by subtracting radiation measured underneath the cap from radiation measured outside the cap and then dividing this difference by the product of radiation measured outside the cap multiplied by 100.

Time frame: 1 day

Population: Mean Radiation Protection is described under Outcome Measure Data below.

ArmMeasureValue (MEAN)
Standard CapRadiation Attenuation in Percentage (%)12 Percentage
0.3mm XPF CapRadiation Attenuation in Percentage (%)91.5 Percentage
0.5mm XPF CapRadiation Attenuation in Percentage (%)97.1 Percentage
Secondary

Operator Comfort Assessment

After completion of the last procedure on each day, the operators were asked to rate the comfort of wearing the cap on a scale from 0 (unbearably heavy, badly fitting) to 100 (very light, well fitting).

Time frame: 1 day per participant, a total of 197 operator days

ArmMeasureValue (MEAN)
Standard CapOperator Comfort Assessment90 score on a scale
0.3mm XPF CapOperator Comfort Assessment90 score on a scale
0.5mm XPF CapOperator Comfort Assessment90 score on a scale
Secondary

Operator Comfort Assessment Based on Weight

After completion of the last procedure on each day, the caps worn by the operators were weighed to assess comfort of wearing the standard cap, XPF 0.3mm and XPF 0.5mm caps. The operators were asked to rate the comfort of wearing the cap on a scale from 0 (unbearably heavy, badly fitting) to 100 (very light, well fitting).

Time frame: 1 day per participant, a total of 197 operator days

ArmMeasureValue (MEAN)
Standard CapOperator Comfort Assessment Based on Weight12.5 grams
0.3mm XPF CapOperator Comfort Assessment Based on Weight123.7 grams
0.5mm XPF CapOperator Comfort Assessment Based on Weight118.4 grams

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026